ICU Medical Inc (ICUI) stock
ICUINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3086% above fair value
$176.91−4.96 (-2.73%)
Close on Nov 17, 2026Market cap $4.42BP/E 147.4Yield –
ICU Medical operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
ICU Medical's operating income for the twelve months ending Jun 30, 2026 was $72.06M, up 3.8% year over year. For fiscal 2025 it was $42.83M, down 0.3% from the year before. Over ten years it grew -4.6% a year on average. The highest annual figure on record is $123.25M in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $42.83M | -0.3% |
| FY2024 | Dec 31, 2024 | $42.96M | +88.2% |
| FY2023 | Dec 31, 2023 | $22.83M | – |
| FY2022 | Dec 31, 2022 | -$42.90M | -134.8% |
| FY2021 | Dec 31, 2021 | $123.25M | +25.6% |
| FY2020 | Dec 31, 2020 | $98.16M | -8.6% |
| FY2019 | Dec 31, 2019 | $107.36M | +260.8% |
| FY2018 | Dec 31, 2018 | $29.76M | – |
| FY2017 | Dec 31, 2017 | -$13.29M | -116.0% |
| FY2016 | Dec 31, 2016 | $82.94M | +21.0% |
| FY2015 | Dec 31, 2015 | $68.57M | +75.6% |
| FY2014 | Dec 31, 2014 | $39.04M | -24.9% |
| FY2013 | Dec 31, 2013 | $51.95M | -15.2% |
| FY2012 | Dec 31, 2012 | $61.28M | -6.0% |
| FY2011 | Dec 31, 2011 | $65.22M | +36.9% |
| FY2010 | Dec 31, 2010 | $47.66M | +34.5% |
| FY2009 | Dec 31, 2009 | $35.43M | +12.9% |
| FY2008 | Dec 31, 2008 | $31.38M | +27.3% |
| FY2007 | Dec 31, 2007 | $24.65M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $39.13M | +269.6% |
| Q1 FY2026 | Mar 31, 2026 | $13.58M | +5.4% |
| Q4 FY2025 | Dec 31, 2025 | $5.64M | -85.0% |
| Q3 FY2025 | Sep 30, 2025 | $13.72M | +66.6% |
| Q2 FY2025 | Jun 30, 2025 | $10.59M | +37.6% |
| Q1 FY2025 | Mar 31, 2025 | $12.89M | – |
| Q4 FY2024 | Dec 31, 2024 | $37.69M | – |
| Q3 FY2024 | Sep 30, 2024 | $8.24M | -64.0% |
| Q2 FY2024 | Jun 30, 2024 | $7.69M | +178.7% |
| Q1 FY2024 | Mar 31, 2024 | -$10.66M | -213.4% |
| Q4 FY2023 | Dec 31, 2023 | -$12.18M | – |
| Q3 FY2023 | Sep 30, 2023 | $22.85M | – |
| Q2 FY2023 | Jun 30, 2023 | $2.76M | – |
| Q1 FY2023 | Mar 31, 2023 | $9.40M | – |
| Q4 FY2022 | Dec 31, 2022 | -$222.00K | -100.9% |
| Q3 FY2022 | Sep 30, 2022 | -$467.00K | -101.2% |
| Q2 FY2022 | Jun 30, 2022 | -$48.00K | -100.1% |
| Q1 FY2022 | Mar 31, 2022 | -$42.16M | -258.7% |
| Q4 FY2021 | Dec 31, 2021 | $23.83M | -11.8% |
| Q3 FY2021 | Sep 30, 2021 | $38.38M | +50.3% |
| Q2 FY2021 | Jun 30, 2021 | $34.47M | +76.3% |
| Q1 FY2021 | Mar 31, 2021 | $26.57M | +2.0% |
| Q4 FY2020 | Dec 31, 2020 | $27.02M | +51.6% |
| Q3 FY2020 | Sep 30, 2020 | $25.53M | -22.4% |
| Q2 FY2020 | Jun 30, 2020 | $19.56M | -25.5% |
| Q1 FY2020 | Mar 31, 2020 | $26.06M | -14.2% |
| Q4 FY2019 | Dec 31, 2019 | $17.82M | – |
| Q3 FY2019 | Sep 30, 2019 | $32.90M | +1359.6% |
| Q2 FY2019 | Jun 30, 2019 | $26.27M | -17.2% |
| Q1 FY2019 | Mar 31, 2019 | $30.37M | +518.1% |
| Q4 FY2018 | Dec 31, 2018 | -$9.13M | -121.1% |
| Q3 FY2018 | Sep 30, 2018 | $2.25M | – |
| Q2 FY2018 | Jun 30, 2018 | $31.72M | – |
| Q1 FY2018 | Mar 31, 2018 | $4.91M | – |
| Q4 FY2017 | Dec 31, 2017 | $43.32M | +214.6% |
| Q3 FY2017 | Sep 30, 2017 | -$3.70M | -116.5% |
| Q2 FY2017 | Jun 30, 2017 | -$35.93M | – |
| Q1 FY2017 | Mar 31, 2017 | -$16.98M | – |
| Q4 FY2016 | Dec 31, 2016 | $13.77M | – |
| Q3 FY2016 | Sep 30, 2016 | $22.46M | – |
See a number that looks wrong?